Seokki Lee is Associate Executive Director of Dongwoon Anatech (KOSDAQ: 094170), leading the in vitro diagnostics division. As former Vice President of R&D of Osang Healthcare (KOSDAQ: 036220), he led the commercialization of 12 FDA/CE-approved diagnostic tests, ranging from diabetes care, infectious diseases, and cardiovascular disorders. He led the commercialization of the first FDA/CE approved COVID-19 rapid PCR test in Korea. With extensive experience in in vitro diagnostics product development, commercial manufacturing, quality management, and regulatory affairs, he serves on the planning committee of the Ministry of Trade, Industry and Energy.